B-CELL ALL
Clinical trials for B-CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B-CELL ALL trials appear
Sign up with your email to follow new studies for B-CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Chance leukemia therapy offered when standard batch fails
Disease control AVAILABLEThis program provides access to a personalized cell therapy (obe-cel) for adults with a hard-to-treat form of acute lymphoblastic leukemia (ALL). It is for patients whose own manufactured therapy batch did not meet the usual quality standards for commercial use and who cannot saf…
Matched conditions: B-CELL ALL
Sponsor: Autolus Limited • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Do cancer drugs wipe out Kids' vaccine shields? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if a common leukemia treatment called blinatumomab weakens the protection from childhood vaccines. Researchers will check antibody levels in up to 300 young patients (under 21) who have been treated for B-cell leukemia. They want to see if these pati…
Matched conditions: B-CELL ALL
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC